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(ii)1. Current literature highlights
1.1. Metalloproteinase inhibitors
The design, preparation and screening of chemical
libraries in solution or on solid phase has been used for
the rapid identiﬁcation of proteinase inhibitors. The
beneﬁt from the combinatorial chemistry perspective is
in the synthesis of large numbers of compounds which
can be screened simultaneously. In one-bead assays,
the selection process to distinguish hits from non-hits
can be a diﬃcult and laborious task, rarely performed
in a quantitative and reproducible manner. To overcome
these problems, automated sorting machines are now
available to sort spherical beads according to their ﬂuo-
rescent intensity. A one-bead-two-compound library of
phosphinic peptides has been constructed in order to
investigate the reliability of a fully automated bead sort-
ing apparatus in selection of beads containing potent
inhibitors.1
A solid phase library on PEGA1900 was synthesised as a
one-bead-two-compound library producing a theoretical
total of 160,000 phosphinic peptide inhibitors. The
PEGA1900 resin was initially derivatised to provide two
orthogonally protected reaction sites (i). The combina-
torial library was generated from one reaction site whilst
the other enabled the introduction of an internally
quenched ﬂuorogenic substrate. The resulting beads
each carry two distinct compounds: (a) the target for
molecular interaction, a randomly synthesised library
member X3X2-GW[PO2HCH2]LX02X
0
3 and with an N-
substituent of acetyl, H, or H-D-Ala, linked to the sup-
port via a mass/ionisation spacer [GTISRTI], and a
photolabile linker; and (b) an internally quenched ﬂuoro-
genic substrate AY(NO2)GPLGLYARK(Abz)G (-scis-
sile bond) attached directly to the resin. Librarydoi:10.1016/j.comche.2004.11.001
E-mail: nick_terrett@cambridge.pﬁzer.comsynthesis on PEGA1900 provided, after cleavage of com-
pounds from the solid support, phosphinic acids which
were incubated with the 65 kDa MMP-9, which pene-
trated into the PEGA polymer and cleaved the
quenched ﬂuorogenic substrate in beads containing no
inhibitory compound. Pools of approximately 10,000
beads were automatically sorted based on a quantitative
measurement of ﬂuorescence intensity such that the
whole library was sorted in a few hours.
Of those beads found to contain active constituents, ten
sequences found to be active were selected for re-synthe-
sis on PEGA 800 resin using a Rink amide linker for
evaluation as MMP-9 inhibitors in solution. One of
the most active compounds was (ii) which possessed a
Ki for MMP-9 of 1.4 nM. These results demonstrate
that potent MMP inhibitors can be identiﬁed from a
one-bead-two-compound library of phosphinic peptides
using a ﬂuorescence directed automated sorting method.1.2. Neuroprotective K+ channel inhibitors
Potassium (K+) channels play a pivotal role in electrical
activity of all excitable tissues. Abnormalities in K+ cur-
rents results in cardiovascular, neurological, renal and
endocrine pathology. Pharmacological modulation of
speciﬁc K+ currents is recognised as a major strategy
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most small-molecule modulators of K+ channels to date
aﬀect these channels at high micromolar to millimolar
concentrations and lack suﬃcient target speciﬁcity.
Given the diversity of K+ channels, development of more
potent and speciﬁc K+ channel drugs is a high priority
for molecular pharmacology. Hindering their discovery
is the traditional low-throughput capacity of ion chan-
nel assays. An approach to increase the throughput for
screening K+ channel modulators has been tried previ-
ously using yeast that functionally express mammalian
K+ channels. Yeast require K+ and so cannot grow in
low [K+] medium when their endogenous K+ transpo-
rters trk1 and trk2 are disrupted. However, growth of
Dtrk1trk2 knockout yeast in low [K+] medium can be
rescued (genetically complemented) by mammalian
Kir2.1 channel expression. Because this growth in low
[K+] medium depends on the activity of the mammalian
channel, it may be possible to screen for Kir2.1 channel
modulators by monitoring yeast growth.2
Using this approach, the authors identiﬁed a novel K+
channel inhibitor from an initial screen of 10,000 com-
pounds produced in a combinatorial chemistry library.
The library compounds were screened as singletons in
an assay based on growth of yeast that functionally ex-
presses mammalian Kir2.1 channels. From this screen-
ing procedure, 42 potential inhibitors of Kir2.1 were
identiﬁed. One compound, 3-bicyclo[2.2.1]hept-2-ylbenz-
ene-1,2-diol was conﬁrmed to inhibit K+ channels in
patch-clamp measurements in mammalian calls with
EC50 values of 60 and 1 lM for Kir2.1 and Kv2.12
channels, respectively. Therefore, yeast-based screening
has identiﬁed a novel neuroprotective mammalian
K+ channel inhibitor and this approach may prove use-
ful in the search for further novel ion channels.2. A summary of the papers in this months issue
2.1. Solid-phase synthesis
A traceless solid-phase synthetic approach to isoquinoli-
nones has been described. This method introduces both
electron-donating as well as electron-withdrawing moie-
ties on the benzene nuclei of isoquinolinones with high
yields and purities.3
Polymer-supported isocyanides have been synthesised,
from commercial Wang and HMBA-AM resins, and re-
acted under radical conditions with 2-mercaptoethanol
and ethanethiol to give the corresponding pyrrolidine
or pyroglutamic acid derivatives in good yields.4
The synthesis of pseudopeptides on solid supports, in
order to quickly obtain modiﬁed peptides has been
investigated. A convenient step-by-step synthesis of
ketomethylenimino W[CO–CH@N] and ketomethylen-
amino W[CO–CH2–NH] peptides has been described.5
Tripeptides containing a novel a,a-disubstituted glycine
with two pyridine rings, a,a-di(2-pyridyl)glycine (2Dpy),
have been synthesised by the solid-phase Ugi reactionusing di(2-pyridyl)methanimine attached directly to a
Rink amide resin.6
The traceless solid-phase synthesis of quinolines has
been accomplished by treating resin-bound enol ethers
with TFA and then oxidizing with manganese dioxide
to give 2-substituted quinolines in high purity without
the need for chromatography.7
Polymer-substituted dihydrofurans and tetrahydrofu-
rans have been synthesised through polymer-supported
selenium-induced intramolecular electrophilic cyclisa-
tion, followed by selenoxide syn-elimination or novel
nucleophilic substitution cleavage of selenium resin with
good yields and purities.8
2.2. Solution-phase synthesis
A convenient and diversity-oriented method for synthe-
sis of the novel 7-aryl-3,4,5,6-tetrahydro-2H-pyrido[4,5-
b]-1,5-oxazocine-6-one skeleton and the very rarely de-
scribed 7-aryl-3,4,5,6-tetrahydro-2H-pyrido[2,3-b]-1,5-
oxazocine-6-one skeleton, featuring cyclisation using
nucleophilic aromatic substitution (SNAr) and Suzuki
coupling, has been described.9
Olssons one pot, three-component reaction of cycloprop-
ylketones, aldehydes, and primary amines has been
investigated for application to parallel synthesis provid-
ing an eﬃcient synthetic route to 3-alkylidenyl-
pyrrolidines.10
2.3. Scaﬀolds for combinatorial libraries
No papers this month.
2.4. Solid-phase supported reagents
A variety of aryl nitriles have been prepared in excellent
yields from the palladium acetate catalysed coupling of
aryl halides with Zn(CN)2 using polymer-supported tri-
phenyl phosphine as the ligand and dimethylformamide
as solvent under microwave irradiation conditions.11
2.5. Novel resins, linkers and techniques
Optimization of the Heck reaction of 4-bromoacetophe-
none with styrene by a polymer supported, sulphur-con-
taining palladacycle, varying six factors at a total of 28
diﬀerent levels, corresponding to 5760 diﬀerent possibil-
ities has been undertaken.12
A rapid method for the qualitative detection of hydroxyl
groups on solid-phase has been developed. The method
employs N-methylisatoic anhydride to derivatise resin-
bound substrates possessing free hydroxyl functionality,
and the resultant ﬂuorescent ester can be detected by
visualisation under a standard laboratory UV lamp at
365 nm excitation.13
The previously proposed concept of using mixtures of
two diﬀerent chiral monodentate P-ligands has been ex-
tended to the asymmetric Rh-catalyzed hydrogenation
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no acid derivatives. The power of this combinatorial ap-
proach arises from the ready access to catalyst diversity
without the need to synthesize new ligands.14
2.6. Library applications
A concise, eﬃcient and ﬂexible total synthesis of the
potent antitumor agent TMC-69-6H has been described.
The ﬂexibility inherent to this route allows for the prep-
aration of a focused library of analogues for biochemi-
cal evaluation with the results obtained showing that
N-hydroxy-2-pyridone derivatives constitute a promis-
ing new class of selective phosphatase inhibitors.15
Screening of a combinatorial CTV-based artiﬁcial, syn-
thetic receptor library for binding of a variety D-Ala-
D-Ala and D-Ala-D-Lac containing ligands has been
carried out. After screening and Edman sequencing, syn-
thetic receptors were found containing amino acid se-
quences, which are either characteristic for binding dye
labelled D-Ala-D-Ala or D-Ala-D-Lac containing
ligands.16
A targeted library of small molecules has been prepared
to optimise the biological activity of a lead compound,
recently described as an original inhibitor of CDC25
phosphatases. Some of these compounds inhibit
CDC25 in the micromolar range and therefore reinforce
the interest of CDC25 as an anticancer target.17
A series of potent and selective inhibitors of ADAM12
have been discovered using computational screening of
a focused virtual library.18
A solution-phase multiple-parallel synthesis approach
has been employed for the preparation of 6-, 7- and 8-
aryl-substituted chromenone libraries, which were
screened as inhibitors of the DNA repair enzyme
DNA-dependent protein kinase (DNA-PK).19References
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